Ultromics' EchoGo® Amyloidosis, clinical AI for echocardiography with the potential to revolutionize early detection of ...
BrightHeart announced that it received FDA 510(k) clearance for its first AI software for prenatal ultrasound evaluations of ...
FDA Breakthrough Device Designation is granted to UNEEG's Subcutaneous EEG Implant System and will expedite the review of ...
The device was among 15 breakthrough cardiovascular ... the University of Oxford (UK), has expanded its portfolio of FDA-cleared, AI-based Echo diagnostics to include EchoGo ® Amyloidosis.
The software is designed to improve the accuracy of detecting morphological abnormalities during foetal heart ultrasound ...
The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...
New study finds that AI didn't help reduce radiologists' burnout, HHS called out for not auditing HIPAA compliance, and more.
New features include advanced analysis of multiple sclerosis (MS) and white matter hyperintensities alongside brain atrophy ...
BrightHeart, a leading AI innovator in obstetric and pediatric cardiology technology, announces it has received FDA 510(k) clearance for its first artificial intelligence software, designed to ...